racotumomab: Clinical Trials

4 trials of racotumomab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1
Phase 31Unknown 1

Follow racotumomab: new trials by email Literature Review of racotumomab trials Research Report on racotumomab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Racotumomab in Patients With High-risk Neuroblastoma
Racotumomab - Neuroblastoma
Phase 2CompletedLaboratorio Elea Phoenix S.A.392016-11-012023-09-11
Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides
racotumomab - Neuroblastoma, Ewing's Sarcoma
Phase 1CompletedLaboratorio Elea Phoenix S.A.152011-02-012015-07-29
Immunotherapy With Racotumomab in Advanced Lung Cancer
Racotumomab, Best Support Treatment - NSCLC, Lung Cancer, Non-small Cell
Phase 3UnknownRecombio SL10822010-09-012016-07-29
Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients
racotumomab, Best support treatment - Advanced Non-small Cell Lung Cancer
Phase 2CompletedLaboratorio Elea Phoenix S.A.72009-09-012014-07-10

Conditions studied

Neuroblastoma (2)  ·  Small Cell Lung Carcinoma (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Glioma (1)  ·  Retinoblastoma (1)  ·  Sarcoma, Ewing (1)  ·  Wilms Tumor (1)

Sponsors

Laboratorio Elea Phoenix S.A. (3)  ·  Recombio SL (1)

Countries

Argentina (4)  ·  Brazil (1)  ·  Cuba (1)  ·  Indonesia (1)  ·  Philippines (1)  ·  Singapore (1)  ·  Thailand (1)

Top investigators

Walter Cacciavillano, MD (2)  ·  Gabriela Cinat, MD (1)  ·  Guillermo Chantada, MD (1)  ·  Roberto Gomez, M.D. (1)

Results publications

PMID 26154941, PMID 42136000